Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective U.S. study

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 11, 1999, Pages 2612-2623

  Thornsberry, C ^a   Ogilvie, P T ^a,d   Holley Jr , H P ^c,e   Sahm, D F ^b  

^a MRL Pharmaceutical Services   (United States)

^b MRL Pharmaceutical Services   (United States)

^c GLAXOSMITHKLINE   (United States)

^d Home Healthcare Labs of America   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GREPAFLOXACIN; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; EYE INFECTION; GEOGRAPHY; HAEMOPHILUS INFLUENZAE TYPE A; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0032733722     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.11.2612     Document Type: Article

References (22)

1. Baron, E. J., and P. R. Murray. 1995. Bacteriology, p. 246-662. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
2. Bartlett, J. G., R. F. Breiman, L. A. Mandell, and T. M. Fole. 1998. Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26:811-838.
3. Butler, J. C., J. Hofmann, M. S. Cetron, J. A. Elliott, R. R. Facklam, and R. F. Breiman. 1996. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J. Infect. Dis. 174:986-993.
4. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
5. Doern, G. V., A. B. Brueggemann, G. Pierce, T. Hogan, H. P. Holley, Jr., and A. Rauch. 1996. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:2884-2886.
6. Doern, G. V., A. B. Braeggemann, G. Pierce, H. P. Holley, Jr., and A. Rauch. 1997. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41:292-297.
7. Doern, G. V., R. N. Jones, M. A. Pfaller, K. Kugler, and The Sentry Participants Group. 1999. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob. Agents Chemother. 43:385-389.
8. Doern, G. V., M. A. Pfaller, K. Kugler, J. Freeman, and R. N. Jones. 1998. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. Clin. Infect. Dis. 27:764-770.
9. Hansman, D., and M. M. Bullen. 1967. A resistant pneumococcus. Lancet ii:264-265. (Letter.)
10. Hickey, M. L., C. Thornsberry, D. R. Diakun, S. V. Mani, and D. F. Sahm. 1998. Activity of ciprofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis: has it changed in the last decade?, abstr. E-20, p. 172. In Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. Hogan, P. A., and D. J. Sheehan. 1998. Macrolide susceptibility and β-lactamase production among Haemophilus influenzae isolates in the United States, 1996-1997. Antimicrob. Agents Chemother. 42:3313-3314.
12. Klein, J. O. 1995. Selection of oral antimicrobial agents for otitis media and pharyngitis. Infect. Dis. Clin. Pract. 4(Suppl. 2):S88-S94.
13. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. National Committee for Clinical Laboratory Standards. 1998. Performance standards for antimicrobial susceptibility testing; eighth informational supplement. Approved standard, document M100-S8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
16. Thornsberry, C., S. D. Brown, Y. C. Yee, S. K. Bouchillon, J. K. Marler, and T. Rich. 1993. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S. Infect. Med. 12(Suppl.):S15-S24.
17. Thornsberry, C., M. L. Mickey, D. R. Diakun, S. V. Mani, M. E. Jones, and D. F. Sahm. 1999. International surveillance of susceptibility to levofloxacin and other agents among respiratory pathogens. Drugs 58(Suppl. 2):364-365.
18. Thornsberry, C., M. L. Hickey, Y. Mauriz, J. Kahn, and D. F. Sahm. 1999. Surveillance of antimicrobial resistance among respiratory tract pathogens in the United States, 1997 to 1998. Drugs S8(Suppl. 2):361-363.
19. Thornsberry, C., P. Ogilvie, and H. P. Holley, Jr. 1997. The activity of fluoroquinolones and other antimicrobial agents against community isolates of S. pneumoniae (Sp), H. influenzae (Hi), and M. catarrhalis (Mc), abstr. E-3, p. 114. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Thornsberry, C., P. Ogilvie, H. P. Holley, Jr., M. L. Hickey, M. E. Jones, I. A. Critchley, and D. F. Sahm. 1999. The activity of fluoroquinolones and other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Drugs 58(Suppl. 2):346-348.
21. Thornsberry, C., P. Ogilvie, J. Kahn, and Y. Mauriz. 1997. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagn. Microbiol. Infect. Dis. 29:249-257.
22. Walker, R. D., and C. Thornsberry. 1998. Decrease in antibiotic susceptibility or increase in resistance? J. Antimicrob. Chemother. 41:1-4.